Marinomed Biotech AG | WebDisclosure

Basculer en Français

10069	Companies
205847	Keywords
136110	Articles
109148	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 12/19/2024 at 12:39, 1 year 3 months ago

Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division
Marinomed Biotech AG's extraordinary general meeting approves sale of Carragelose division, ensuring implementation of restructuring plan. Dr. Karl Mahler elected to the Supervisory Board

Supervisory Board Marinomed Biotech AG Restructuring Plan Sale Approval Carragelose Division
BRIEF

published on 12/17/2024 at 13:05, 1 year 3 months ago

Marinomed Biotech AG franchit une étape importante dans sa restructuration

Obligation Convertible Financement Des Biotechnologies Vente De Carraghénose Restructuration De Marinomed Accord BEI
BRIEF

published on 12/17/2024 at 13:05, 1 year 3 months ago

Marinomed Biotech AG Achieves Restructuring Milestone

Convertible Bond Carragelose Sale Marinomed Restructuring EIB Agreement Biotech Finance
PRESS RELEASE

published on 12/17/2024 at 13:00, 1 year 3 months ago

Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved
Marinomed Biotech AG successfully meets requirements for restructuring with funds deposited for cash quota & legal costs. European Investment Bank standstill agreement secured for completion. Sale of Carragelose business to ensure sustainable existence

Restructuring Marinomed Biotech AG Financial Stability Carragelose Sale EIB Agreement
BRIEF

published on 12/05/2024 at 14:39, 1 year 3 months ago

Marinomed Biotech AG Announces Second Capital Increase

Investment Capital Increase Share Issuance Marinomed Biotech AG Financial Strategy
BRIEF

published on 12/05/2024 at 14:39, 1 year 3 months ago

Marinomed Biotech AG annonce sa deuxième augmentation de capital

Investissement Stratégie Financière Augmentation De Capital Marinomed Biotech AG Émission D'actions
PRESS RELEASE

published on 12/05/2024 at 14:34, 1 year 3 months ago

EQS-Adhoc: Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value bearer shares at an issue price of EUR 8 per share
Marinomed Biotech AG resolves second capital increase by issuing 83,750 bearer shares at EUR 8 per share, excluding subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights 83,750 Shares EUR 8
BRIEF

published on 11/27/2024 at 13:39, 1 year 3 months ago

Marinomed Biotech AG accepte l'émission d'obligations convertibles auprès de la BEI

Marinomed Biotech AG Droits Des Actionnaires Banque Européenne D'investissement Obligation Convertible Action D'entreprise
BRIEF

published on 11/27/2024 at 13:39, 1 year 3 months ago

Marinomed Biotech AG Agrees to Convertible Bond Issuance with EIB

Shareholder Rights Marinomed Biotech AG Convertible Bond European Investment Bank Corporate Action
PRESS RELEASE

published on 11/27/2024 at 13:34, 1 year 3 months ago

EQS-Adhoc: Marinomed Biotech AG: Binding Term Sheet for the intended issuance of a convertible bond to the European Investment Bank (EIB) signed
Marinomed Biotech AG signs Binding Term Sheet with European Investment Bank for convertible bond issuance. Convertible bond to be issued in December 2024

Marinomed Biotech AG Convertible Bond European Investment Bank Issuance Binding Term Sheet

Accesswire

Published on 03/23/2026 at 22:40, 1 hour 29 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 1 hour 39 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 2 hours 9 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 2 hours 51 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 10 hours 4 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 22:05, 2 hours 4 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 3 hours 4 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 3 hours 4 minutes ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 3 hours 9 minutes ago

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 3 hours 14 minutes ago

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Les Echos

Published on 03/23/2026 at 19:08, 5 hours 1 minute ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 5 hours 1 minute ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 5 hours 32 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 6 hours 24 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 6 hours 24 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE